Product Description
Short-Acting GHRH Research Peptide
CJC-1295 without DAC, also known as Mod GRF 1-29, is a short-acting synthetic peptide designed to mimic the signaling activity of growth hormone-releasing hormone, or GHRH. It is studied for its ability to stimulate temporary, pulsatile growth hormone release while preserving the body’s natural endocrine rhythm.
Unlike longer-acting DAC-modified analogs, CJC-1295 No DAC is generally associated with a brief research activity window of approximately 30 to 60 minutes. This short duration allows researchers to examine sharp GH signaling pulses rather than continuously elevated pathway activity and provides greater control when adjusting experimental variables.
Key Research Areas
🧬
GHRH receptor and pituitary GH-axis signaling in laboratory models examining endogenous growth hormone release
⚡
Short-duration pulsatile GH release designed to model temporary hormone spikes rather than continuously elevated signaling
🔄
Natural endocrine rhythm preservation and reduced continuous receptor stimulation in controlled GH-axis research
🌙
Sleep-related growth hormone patterns involving the natural GH surge associated with deep-rest cycles
💪
Muscle recovery and tissue-repair signaling in models involving exercise stress, soft-tissue strain, and regenerative pathways
⚙️
Body-composition and metabolic research examining fat metabolism, lean-mass retention, and combination models involving secretagogues such as Ipamorelin
This 10 mg presentation supports controlled short-acting GH-axis research designs, making it suitable for investigations across pulsatile growth hormone release, receptor responsiveness, natural endocrine rhythms, sleep-related signaling, tissue repair, exercise recovery, fat metabolism, and lean-mass preservation.
Intended Use
📦 Format: Lyophilized powder (10mg)
🧬 Compound: CJC-1295 No DAC, also known as Mod GRF 1-29
⚠️ Use: For laboratory research use only. Not for human or veterinary use.
Why Researchers Choose This Compound
🌊
Pulsatile signaling profile supports investigation of sharp, temporary growth hormone release patterns that more closely reflect natural endocrine rhythms.
⏱️
Short research activity window provides greater experimental control and allows variables to be stopped or adjusted more quickly than with longer-acting analogs.
🔄
Reduced continuous receptor exposure supports models examining pituitary responsiveness without maintaining prolonged GH-axis stimulation.
📈
Broad recovery and metabolic relevance offers a controlled framework for studying sleep-related GH signaling, muscle repair, tissue recovery, fat metabolism, and lean-mass retention.
Product Notes
✅ Research category: GHRH, growth hormone, and endocrine signaling
✅ Study context: Laboratory and non-clinical research models
✅ Alternate name: Mod GRF 1-29
✅ Activity profile: Short-acting and pulsatile, with an approximate 30–60 minute research window
✅ Compound focus: GHRH receptor signaling, pituitary responsiveness, natural GH pulses, sleep-related endocrine patterns, recovery, tissue repair, fat metabolism, and lean-mass research
